| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |